Csenge Advisory Group United Therapeutics Corp Transaction History
Csenge Advisory Group
- $1.81 Billion
- Q4 2024
A detailed history of Csenge Advisory Group transactions in United Therapeutics Corp stock. As of the latest transaction made, Csenge Advisory Group holds 1,791 shares of UTHR stock, worth $630,969. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,791
Previous 2,062
13.14%
Holding current value
$630,969
Previous $738,000
14.5%
% of portfolio
0.03%
Previous 0.04%
Shares
11 transactions
Others Institutions Holding UTHR
# of Institutions
679Shares Held
42.1MCall Options Held
194KPut Options Held
298K-
Black Rock Inc. New York, NY5.47MShares$1.93 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.41MShares$1.55 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA3.17MShares$1.12 Billion0.2% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.86MShares$1.01 Billion15.42% of portfolio
-
State Street Corp Boston, MA2.24MShares$789 Million0.03% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $16B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...